Live Dana-Farber Cancer Institute News with Latest Updates

Live Dana-Farber Cancer Institute news and developments with the latest updates. Check out current Dana-Farber Cancer Institute news stories and find out what happened, what is going on with Dana-Farber Cancer Institute. Recent news updates about Dana-Farber Cancer Institute
Dana-Farber Cancer Institute researcher awarded funding from Chan Zuckerberg Initiative for Open
Dana-Farber Researcher awarded 2019 Paul Marks Prize for Cancer Research
Dana-Farber named one of most noteworthy MA companies and non-profits led by women
Dana-Farber Cancer Institute earns “LGBTQ Health Care Equality Top Performer” Designation
Study finds racial disparities in culturally competent cancer care
Small molecule inhibitor shows clinical activity in lung and colorectal cancer patients
Dana-Farber Cancer Institute launches new national advertising campaign
Dana-Farber Cancer Institute faculty elected to National Academy of Medicine
Dana-Farber Cancer Institute Receives Largest Gift Ever, a Record-Breaking $63 Million
Eric Winer, MD honored with Jill Rose Award by Breast Cancer Research Foundation
Cause of drug resistance in a type of intestinal tumors identified
William G. Kaelin, MD, of Dana-Farber Cancer Institute wins 2019 Nobel Prize
New blood test capable of detecting multiple types of cancer
Dana-Farber Cancer Institute and Jimmy Fund debut new visual identity
Resistance to immune checkpoint blocker drug linked to metabolic imbalance
Chronic insomnia can be cured in cancer survivors with a basic, one-session sleep education class
Dana-Farber Cancer Institute receives $5 million gift to create Edward P. Evans Center
Study shows benefit of PARP inhibitor for some ovarian cancer patients
Beth Mittendorf, MD, PhD will lead new Stand Up to Cancer research team
Statement on Medical Deferred Action Program – August 31, 2019
Dana-Farber/Brigham and Women’s Cancer Center receives largest individual gift for glioblastoma
Exposure to second-hand e-cigarette aerosols increasing among young people, Dana-Farber study finds
Dana-Farber Cancer Institute is awarded its fourth consecutive designation as a Magnet organization
“Stapled” antimicrobial peptides could combat antibiotic resistance
Exercise associated with benefit to patients with advanced colorectal cancer
Inherited pancreatic cancer risk mutation identified
U.S. News & World Report Names Dana-Farber/Brigham and Women’s Cancer Center Among Best
AI tool identifies cancer outcomes using radiology reports
Dana-Farber physician-scientist David Braun honored as Next Gen Innovator
To understand a childhood brain tumor, researchers turn to single-cell analysis
Dana-Farber scientists and associates receive major grant from Gray Foundation for research into
Discovery of a New Immune Process Could Lead to Better Pain Treatments
Two Dana-Farber physician scientists receive 2019 Clinical Scientist Development Award
Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence
High doses of 60-plus year-old chemotherapy drug found to spur immune system attack
Dana-Farber announces $20 million gift from Saverin Family for metastatic breast cancer
Preoperative Management of Inflammation May Stave Off Cancer Recurrences
Dana-Farber researcher selected to join Pew Scholars Program
Clinical trial underscores promise of immunotherapy, in combination with second drug
Dana-Farber researcher is one of three young scientists awarded 2019 Michelson Prize
Laurie H. Glimcher elected to membership of American Philosophical Society
Radiation Treatment Increases Cardiac Risk for Lung Cancer Patients
Walking speed points to future clinical outcomes for older patients with blood cancers
Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer
Pre-surgical immunotherapy shows promise in trial for patients with early stage lung cancer
Patterns of chronic lymphocytic leukemia growth identified